CRSP – crispr therapeutics ag - common shares (US:NASDAQ)

News

1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com